Development
Medtronic plc
MDT
$87.44
$0.440.51%
NYSE
| 01/26/2024 | 10/27/2023 | 07/28/2023 | 04/28/2023 | 01/27/2023 | |
|---|---|---|---|---|---|
| Revenue | 4.68% | 5.26% | 4.49% | 5.64% | -0.46% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.68% | 5.26% | 4.49% | 5.64% | -0.46% |
| Cost of Revenue | 4.02% | 9.23% | 4.65% | 14.97% | 9.50% |
| Gross Profit | 5.04% | 3.29% | 4.41% | 1.30% | -5.01% |
| SG&A Expenses | 2.70% | 2.74% | 2.40% | 1.78% | 2.94% |
| Depreciation & Amortization | -2.78% | 0.95% | 1.42% | 1.77% | -0.23% |
| Other Operating Expenses | -16.67% | -304.35% | -38.55% | 17.21% | -66.67% |
| Total Operating Expenses | 2.59% | 4.17% | 2.03% | 7.87% | 4.10% |
| Operating Income | 14.55% | 10.09% | 16.93% | -1.96% | -17.49% |
| Income Before Tax | 7.13% | -5.81% | 14.77% | -3.19% | -13.58% |
| Income Tax Expenses | -7.53% | -58.08% | 257.14% | 229.09% | 37.74% |
| Earnings from Continuing Operations | 8.88% | 109.43% | -14.39% | -20.32% | -17.25% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -150.00% | 75.00% | -200.00% | -50.00% | -50.00% |
| Net Income | 8.18% | 112.88% | -14.85% | -20.61% | -17.43% |
| EBIT | 14.55% | 10.09% | 16.93% | -1.96% | -17.49% |
| EBITDA | 8.21% | 6.87% | 11.14% | -11.80% | -12.11% |
| EPS Basic | 8.22% | 112.76% | -14.93% | -20.18% | -16.59% |
| Normalized Basic EPS | 12.09% | 3.82% | 17.11% | 7.78% | -8.17% |
| EPS Diluted | 7.76% | 112.50% | -15.57% | -20.03% | -16.48% |
| Normalized Diluted EPS | 12.08% | 3.90% | 17.26% | 8.18% | -7.85% |
| Average Basic Shares Outstanding | -0.04% | 0.06% | 0.08% | -0.54% | -1.00% |
| Average Diluted Shares Outstanding | -0.02% | -0.01% | -0.05% | -0.90% | -1.36% |
| Dividend Per Share | 1.47% | 1.47% | 1.47% | 7.94% | 7.94% |
| Payout Ratio | -0.06% | -0.52% | 0.19% | 0.35% | 0.29% |